vs
Apellis Pharmaceuticals, Inc.（APLS）与达尔科技（DIOD）财务数据对比。点击上方公司名可切换其他公司
达尔科技的季度营收约是Apellis Pharmaceuticals, Inc.的2.0倍（$391.6M vs $199.9M），达尔科技净利率更高（2.6% vs -29.5%，领先32.1%），达尔科技同比增速更快（15.4% vs -5.9%），达尔科技自由现金流更多（$12.4M vs $-14.3M），过去两年达尔科技的营收复合增速更高（13.9% vs 7.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
达尔科技是一家全球性半导体制造商，主营分立器件、模拟及混合信号半导体产品的设计、生产与销售，产品广泛应用于汽车、工业、消费电子、计算及通信基础设施等核心领域，服务全球各地客户。
APLS vs DIOD — 直观对比
营收规模更大
DIOD
是对方的2.0倍
$199.9M
营收增速更快
DIOD
高出21.3%
-5.9%
净利率更高
DIOD
高出32.1%
-29.5%
自由现金流更多
DIOD
多$26.7M
$-14.3M
两年增速更快
DIOD
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $391.6M |
| 净利润 | $-59.0M | $10.2M |
| 毛利率 | — | 31.1% |
| 营业利润率 | -25.6% | 3.4% |
| 净利率 | -29.5% | 2.6% |
| 营收同比 | -5.9% | 15.4% |
| 净利润同比 | -62.2% | 23.8% |
| 每股收益（稀释后） | $-0.40 | $0.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSDIOD
| Q4 25 | $199.9M | $391.6M | ||
| Q3 25 | $458.6M | $392.2M | ||
| Q2 25 | $178.5M | $366.2M | ||
| Q1 25 | $166.8M | $332.1M | ||
| Q4 24 | $212.5M | $339.3M | ||
| Q3 24 | $196.8M | $350.1M | ||
| Q2 24 | $199.7M | $319.8M | ||
| Q1 24 | $172.3M | $302.0M |
净利润APLSDIOD
| Q4 25 | $-59.0M | $10.2M | ||
| Q3 25 | $215.7M | $14.3M | ||
| Q2 25 | $-42.2M | $46.1M | ||
| Q1 25 | $-92.2M | $-4.4M | ||
| Q4 24 | $-36.4M | $8.2M | ||
| Q3 24 | $-57.4M | $13.7M | ||
| Q2 24 | $-37.7M | $8.0M | ||
| Q1 24 | $-66.4M | $14.0M |
毛利率APLSDIOD
| Q4 25 | — | 31.1% | ||
| Q3 25 | — | 30.7% | ||
| Q2 25 | — | 31.5% | ||
| Q1 25 | — | 31.5% | ||
| Q4 24 | — | 32.7% | ||
| Q3 24 | — | 33.7% | ||
| Q2 24 | — | 33.6% | ||
| Q1 24 | — | 33.0% |
营业利润率APLSDIOD
| Q4 25 | -25.6% | 3.4% | ||
| Q3 25 | 48.7% | 3.0% | ||
| Q2 25 | -18.6% | 2.6% | ||
| Q1 25 | -50.0% | 0.4% | ||
| Q4 24 | -12.3% | 3.5% | ||
| Q3 24 | -24.0% | 6.2% | ||
| Q2 24 | -14.7% | 1.2% | ||
| Q1 24 | -36.0% | 4.3% |
净利率APLSDIOD
| Q4 25 | -29.5% | 2.6% | ||
| Q3 25 | 47.0% | 3.6% | ||
| Q2 25 | -23.6% | 12.6% | ||
| Q1 25 | -55.3% | -1.3% | ||
| Q4 24 | -17.1% | 2.4% | ||
| Q3 24 | -29.2% | 3.9% | ||
| Q2 24 | -18.9% | 2.5% | ||
| Q1 24 | -38.5% | 4.6% |
每股收益（稀释后）APLSDIOD
| Q4 25 | $-0.40 | $0.23 | ||
| Q3 25 | $1.67 | $0.31 | ||
| Q2 25 | $-0.33 | $0.99 | ||
| Q1 25 | $-0.74 | $-0.10 | ||
| Q4 24 | $-0.30 | $0.18 | ||
| Q3 24 | $-0.46 | $0.30 | ||
| Q2 24 | $-0.30 | $0.17 | ||
| Q1 24 | $-0.54 | $0.30 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $377.0M |
| 总债务越低越好 | — | $25.7M |
| 股东权益账面价值 | $370.1M | $1.9B |
| 总资产 | $1.1B | $2.4B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资APLSDIOD
| Q4 25 | $466.2M | $377.0M | ||
| Q3 25 | $479.2M | $386.4M | ||
| Q2 25 | $370.0M | $327.3M | ||
| Q1 25 | $358.4M | $343.9M | ||
| Q4 24 | $411.3M | $316.1M | ||
| Q3 24 | $396.9M | $319.3M | ||
| Q2 24 | $360.1M | $273.9M | ||
| Q1 24 | $325.9M | $276.0M |
总债务APLSDIOD
| Q4 25 | — | $25.7M | ||
| Q3 25 | — | $24.9M | ||
| Q2 25 | — | $26.4M | ||
| Q1 25 | — | $20.5M | ||
| Q4 24 | — | $20.7M | ||
| Q3 24 | — | $22.2M | ||
| Q2 24 | — | $20.3M | ||
| Q1 24 | $93.1M | $20.9M |
股东权益APLSDIOD
| Q4 25 | $370.1M | $1.9B | ||
| Q3 25 | $401.2M | $1.9B | ||
| Q2 25 | $156.3M | $1.9B | ||
| Q1 25 | $164.2M | $1.8B | ||
| Q4 24 | $228.5M | $1.8B | ||
| Q3 24 | $237.1M | $1.8B | ||
| Q2 24 | $264.3M | $1.8B | ||
| Q1 24 | $266.7M | $1.7B |
总资产APLSDIOD
| Q4 25 | $1.1B | $2.4B | ||
| Q3 25 | $1.1B | $2.5B | ||
| Q2 25 | $821.4M | $2.5B | ||
| Q1 25 | $807.3M | $2.4B | ||
| Q4 24 | $885.1M | $2.4B | ||
| Q3 24 | $901.9M | $2.4B | ||
| Q2 24 | $904.5M | $2.4B | ||
| Q1 24 | $831.9M | $2.4B |
负债/权益比APLSDIOD
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.01× | ||
| Q1 25 | — | 0.01× | ||
| Q4 24 | — | 0.01× | ||
| Q3 24 | — | 0.01× | ||
| Q2 24 | — | 0.01× | ||
| Q1 24 | 0.35× | 0.01× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $38.1M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $12.4M |
| 自由现金流率自由现金流/营收 | -7.1% | 3.2% |
| 资本支出强度资本支出/营收 | 0.1% | 6.6% |
| 现金转化率经营现金流/净利润 | — | 3.74× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $137.2M |
8季度趋势，按日历期对齐
经营现金流APLSDIOD
| Q4 25 | $-14.2M | $38.1M | ||
| Q3 25 | $108.5M | $79.1M | ||
| Q2 25 | $4.4M | $41.5M | ||
| Q1 25 | $-53.4M | $56.7M | ||
| Q4 24 | $19.4M | $81.8M | ||
| Q3 24 | $34.1M | $54.4M | ||
| Q2 24 | $-8.3M | $14.4M | ||
| Q1 24 | $-133.0M | $-31.1M |
自由现金流APLSDIOD
| Q4 25 | $-14.3M | $12.4M | ||
| Q3 25 | $108.3M | $62.8M | ||
| Q2 25 | $4.4M | $21.1M | ||
| Q1 25 | $-53.4M | $40.8M | ||
| Q4 24 | $19.3M | $62.1M | ||
| Q3 24 | — | $39.4M | ||
| Q2 24 | $-8.4M | $-3.5M | ||
| Q1 24 | $-133.3M | $-51.5M |
自由现金流率APLSDIOD
| Q4 25 | -7.1% | 3.2% | ||
| Q3 25 | 23.6% | 16.0% | ||
| Q2 25 | 2.5% | 5.8% | ||
| Q1 25 | -32.0% | 12.3% | ||
| Q4 24 | 9.1% | 18.3% | ||
| Q3 24 | — | 11.2% | ||
| Q2 24 | -4.2% | -1.1% | ||
| Q1 24 | -77.3% | -17.1% |
资本支出强度APLSDIOD
| Q4 25 | 0.1% | 6.6% | ||
| Q3 25 | 0.0% | 4.2% | ||
| Q2 25 | 0.0% | 5.6% | ||
| Q1 25 | 0.0% | 4.8% | ||
| Q4 24 | 0.0% | 5.8% | ||
| Q3 24 | 0.0% | 4.3% | ||
| Q2 24 | 0.0% | 5.6% | ||
| Q1 24 | 0.2% | 6.7% |
现金转化率APLSDIOD
| Q4 25 | — | 3.74× | ||
| Q3 25 | 0.50× | 5.54× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 9.93× | ||
| Q3 24 | — | 3.95× | ||
| Q2 24 | — | 1.80× | ||
| Q1 24 | — | -2.22× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
DIOD
| Distributor | $253.1M | 65% |
| Direct Sales | $138.5M | 35% |
